Sorafenib as first line treatment for advanced liver cancer-are expiries. Ann Oncol (2011) 23 (suppl 4): iv 57.

Title

Description

J. Rožić, Z. Gojković, S. Jungić, I. Rakita, Ž. Vranješ, R. Rašeta, G. Marić, M. Vještica, S. Mijatović, P. Dašić, M. Vižin, Sorafenib as first line treatment for advanced liver cancer-are expiries. Ann Oncol (2011) 23 (suppl 4): iv 57., This article appears in ESMO 13th World Congres of Gastrointestinal Cancer, 22-25 june 2011., 2011.

Identifier

/unibl/sci/idNaucniRad:8551

Type

See all items with this valueArticle

See all items with this valuetext

Date

See all items with this value2011

Bibliographic Citation

J. Rožić, Z. Gojković, S. Jungić, I. Rakita, Ž. Vranješ, R. Rašeta, G. Marić, M. Vještica, S. Mijatović, P. Dašić, M. Vižin, Sorafenib as first line treatment for advanced liver cancer-are expiries. Ann Oncol (2011) 23 (suppl 4): iv 57., This article appears in ESMO 13th World Congres of Gastrointestinal Cancer, 22-25 june 2011., 2011

presented at

This article appears in ESMO 13th World Congres of Gastrointestinal Cancer, 22-25 june 2011.

list of authors

See all items with this value Jelena Rožić

See all items with this value Zdenka Gojković

See all items with this value S Jungić

See all items with this value Ivanka Rakita

See all items with this value Ž Vranješ

See all items with this value R Rašeta

See all items with this value G Marić

See all items with this value M Vještica

See all items with this value S Mijatović

See all items with this value Predrag Dašić

See all items with this value M Vižin